Market Overview
The global Endovascular Aneurysm Repair Market reached a size of USD 3.1 Billion in 2024. It is projected to grow to USD 4.4 Billion by 2033, exhibiting a CAGR of 3.94% during the forecast period from 2025 to 2033. This growth is primarily driven by the minimally invasive nature of EVAR procedures, increasing adoption by healthcare providers, and the rising prevalence of aneurysm-related conditions among the aging population.
Study Assumption Years
• Base Year: 2024
• Historical Years: 2019-2024
• Forecast Period: 2025-2033
Endovascular Aneurysm Repair Market Key Takeaways
• The global market size was USD 3.1 Billion in 2024.
• The market is expected to grow at a CAGR of 3.94% during 2025-2033.
• The forecast period spans from 2025 to 2033.
• EVAR is a minimally invasive procedure that places a covered stent inside the artery to prevent aneurysm rupture.
• Compared to open surgery, EVAR offers shorter hospital stays, reduced complications, and faster recovery.
• Increasing prevalence of aneurysms and a growing geriatric population are key adoption drivers.
• Government initiatives are improving cost structures and awareness of EVAR treatments.
• Advancements in graft design and device technology are enhancing procedural success rates.
Sample Request Link:
https://www.imarcgroup.com/endovascular-aneurysm-repair-market/requestsample
Market Growth Factors
The increasing prevalence of the aneurysms globally due to tobacco, smoking, atherosclerosis, hypercholesterolemia, and connective tissue disorders is one of the major factors driving the market growth. The increasing patient pool is creating a demand for minimally intrusive treatment options such as endovascular aneurysm repair (EVAR). EVAR consists of inserting a covered stent into the artery, which directs blood away from the aneurysm and lowers the risk of rupture. EVAR is the most commonly used approach because it is safe and has a short recovery time.
EVAR is increasingly being used as it avoids customary open surgery, leading to shorter hospital stays and faster recovery, and there is a wider awareness of the advantages of endovascular surgery for patients and referral audiences. The rise in the geriatric population, which is the most susceptible to aneurysms, is expected to improve the market growth as there will be a demand for safer procedures.
Reducing cost and raising awareness of EVAR devices and therapies through government initiatives in different countries helps spur overall adoption and growth in the market. Healthcare institutions also seek to create new EVAR devices such as advanced grafts that allow for EVAR procedures in patients with short landing zones and/or poor artery conformability for higher success rates and fewer major complications to allow for wider market adoption.
Market Segmentation
By Indication
• Abdominal Aortic Aneurysm (AAA)
• Thoracic Aortic Aneurysm (TAA)
• Thoracoabdominal Aortic Aneurysm (TAAA)
• Others
By Product
• Percutaneous EVAR
• Fenestrated EVAR
• Aortic Stents and Thoracic Aortic Aneurysm Grafts
• Others
By Gender
• Male
• Female
By Age
• Pediatric
• Adult
• Geriatric
By End User
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others
By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
Regional Insights
North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are all covered in the market analysis. These regions are evaluated to provide a comprehensive global outlook for the endovascular aneurysm repair market. Specific regional market share data is not disclosed in the available source information.
Key Players
- Medtronic plc
- Cook Group Incorporated
- W. L. Gore & Associates, Inc.
- Bolton Medical, Inc.
- Gamida Cell Ltd.
- JOTEC GmbH
- Getinge AB (Maquet)
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Terumo Corporation
- Endologix, Inc.
- Lombard Medical Limited
- Cardinal Health, Inc.
Competitive Landscape
The competitive landscape of the endovascular aneurysm repair market is characterized by the presence of global medical device manufacturers focusing on product innovation, improved graft designs, and expanded clinical applications. Strategic collaborations, technological advancements, and regulatory approvals continue to shape market competition.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
Request For Customization: https://www.imarcgroup.com/request?type=report&id=1598&flag=E
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include market assessments, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
